RTA LABORATUVARLARI BIYOLOJIK URUNLER ILAC VE MAKINE SANAYI TICARET

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret

RTALB

TRERTAL00018

Pharmaceuticals

Market Closed - Borsa Istanbul Other stock markets 11:09:44 2024-04-26 am EDT			5-day change	1st Jan Change
12.91 ^TRY	+0.08%		+0.23%	-9.97%

2023	RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S.(IBSE:RTALB) dropped from S&P Global BMI Index

September 19, 2022 at 12:00 am EDT

Latest news about RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-30	CI
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09	CI
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-08	CI
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-09	CI
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S.(IBSE:RTALB) dropped from S&P Global BMI Index	22-09-19	CI
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-19	CI
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-10	CI
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-11	CI
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-09	CI
Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-19	CI
Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-06-09	CI
Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-11	CI
Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-06	CI
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S.(IBSE:RTALB) added to S&P Global BMI Index	20-09-21	CI
Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-12	CI
Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-06-01	CI
Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Full Year Ended December 31, 2019	20-03-04	CI
Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-10-30	CI
Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-09	CI
Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-10	CI
An unknown buyer acquired 13.9% stake in RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. from Mehmet Tayyip Turkaslan.	18-11-15	CI
An unknown buyer acquired 12.3%stake in RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. from Resat Ultav.	18-09-24	CI
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S.'s Equity Buyback announced on July 22, 2016 has expired.	17-12-30	CI
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. announces an Equity Buyback for 100,000 shares, for TRY 1.3 million.	16-07-22	CI
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. authorizes a Buyback plan.	16-07-21	CI

Chart RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret

Duration

Period

Chart RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret

More charts

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS is a Turkey-based company engaged in the research, development and production of in vitro diagnostics. Its diagnostic products include: Clinical Microbiology, such as chromogenic media, culture media in petri dishes, tubes and bottles, rodac petri surcheck, and tuberculosis diagnosis products; ELISA Kits, such as HBsAg ELISA Kit; Molecular Diagnostics, such as nucleic acid isolation kits, real-time PCR instruments, real-time PCR kits and RTA VOLTRAN voral detection system, as well as other tests. Its Research includes: dehydrated culture media, such as dehydrated chromogenic culture media; nucleic acid isolation kits and real-time PCR.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Biopharmaceuticals

	1st Jan change	Capi.
RTA LABORATUVARLARI BIYOLOJIK URUNLER ILAC VE MAKINE SANAYI TICARET	-9.97%	39.77M
CSL LIMITED	-4.52%	86.13B
SAMSUNG BIOLOGICS CO.,LTD.	+1.32%	39.82B
BIOGEN INC.	-19.27%	30.42B
UCB	+57.86%	25.23B
BIOMARIN PHARMACEUTICAL INC.	-16.09%	15.36B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9.14%	11.95B
INCYTE CORPORATION	-17.69%	11.6B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43.00%	11.51B
SWEDISH ORPHAN BIOVITRUM AB	+5.24%	8.71B